Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumors
- 1 December 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 105 (6) , 1909-1911
- https://doi.org/10.1016/0016-5085(93)91091-u
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumorsGastroenterology, 1993
- Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.Radiology, 1993
- Metastatic Carcinoid Tumors and the Malignant Carcinoid SyndromeActa Oncologica, 1993
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsLife Sciences, 1991
- Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasmsCancer, 1991
- Somatostatin-Receptor Imaging in the Localization of Endocrine TumorsNew England Journal of Medicine, 1990
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986